Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest atopic dermatitis Stories

2009-03-05 16:00:00

SAN FRANCISCO, March 5 /PRNewswire-USNewswire/ -- Atopic dermatitis, the common, chronic, inflammatory skin disease marked by red, itchy rashes, has been increasing in prevalence over the past two decades and affects a disproportionate number of children. According to current estimates, approximately 15 percent to 20 percent of children in the United States and other industrialized countries around the world develop atopic dermatitis in the first few years of life. By comparison, only an...

2009-03-05 08:08:00

New Study in the Journal of Cosmetic Dermatology Finds Over-the-Counter (OTC) Albolene(R) Moisturizing Cleanser as Effective as a Prescription Moisturizer for Helping to Clear Up Mild to Moderate Eczema EDISON, N.J., March 5 /PRNewswire/ -- Mild to moderate eczema sufferers who are looking for a cost-effective way to control and heal this skin condition without a prescription now have a new option to consider. A new study in the March 2009 issue of the Journal of Cosmetic Dermatology(1)...

2009-02-09 08:04:00

A Once-Daily Topical Agent With a Novel Mechanism of Action and Efficacy Advantages Over Elidel Would Earn Higher Patient Share in the U.S. Than in Europe, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that high and super-high potency topical corticosteroids (TCSs) will remain Decision Resources' proprietary clinical gold...

2009-01-13 04:00:00

MEMPHIS, Tenn., Jan. 13 /PRNewswire/ -- The National Eczema Association (NEA) awarded its Seal of Acceptance to Theraplex Emollient and Theraplex Clear Lotion. The NEA Seal of Acceptance is part of the association's Eczema & Sensitive-Skin Education (EASE) program, which is intended to improve the quality of life for children and adults who suffer from eczema and sensitive skin. "These products met our criteria for having no irritating ingredients and being suitable for...

2008-11-10 18:00:05

Research findings presented at the 2008 American College of Allergy, Asthma and Immunology (ACAAI) Scientific Meeting revealed a significant cost savings associated with allergy immunotherapy (IT) in children with allergic rhinitis (AR). This pioneering study, supported by Greer, was summarized during an oral presentation by Cheryl Hankin, Ph.D., President and Chief Scientific Officer of BioMedEcon and principal investigator of the study, at the ACAAI meeting, held Nov. 6-11 in Seattle, Wash....

2008-11-07 09:00:25

BioCis Pharma, a privately-held drug development company, has initiated Phase IIa clinical testing of ProtoCure emulsion cream, the company's novel topical drug for dermatology. The double-blind, vehicle-controlled study is designed to evaluate the tolerability and efficacy of the topical product in a total of 18 subjects with mild to moderate forms of atopic dermatitis. The subjects will apply ProtoCure emulsion cream up to four weeks to the skin areas affected by the disease. Lasse...

2008-10-31 09:00:28

Welichem Biotech, a development-stage biopharmaceutical company, has announced positive results from its Phase IIa clinical trial of its drug candidate, WBI-1001, a new, non-steroid, topical cream treatment for atopic dermatitis. In the trial, two concentrations (0.5% and 1%) of WBI-1001 were tested against the placebo. Both WBI-1001 cream concentrations were superior to placebo in deceasing atopic dermatitis (AD) and showed an excellent safety profile. This clinical Phase IIa trial for...

2008-10-30 03:00:13

Provectus Pharmaceuticals has successfully completed its Phase I clinical trial of PV-10 in the treatment of recurrent breast carcinoma. Provectus is currently conducting Phase II clinical trials of its proprietary drugs PV-10 as a therapy for metastatic melanoma and PH-10 as a topical treatment for psoriasis and atopic dermatitis. Craig Dees, CEO of Provectus, said: "We are very pleased with the results of this Phase I clinical trial, a classic ascending dose study. Its goals were to...

2008-10-28 11:30:00

Chronic stress can lead to skin irritation and persistent itching that leads to bothersome scratching, a Canadian neuroimmunologist reported in a study. Dr. Petra Arck of McMaster University in Hamilton, Ontario, said her early research involved subjecting mice to stress in the form of lengthy bouts of unpleasant noise. She said a wave of immune cells moved into the mice's skin and made them itch, the Ottawa Citizen reported. It was already known isolated incidents of stress mobilize...

2008-10-27 09:00:41

LA JOLLA, Calif., Oct 27 /PRNewswire/ -- DermTech, a biotechnology company developing EGIR(TM) (Epidermal Genetic Information Retrieval) technology for the non-invasive early detection of melanoma, drug development and other applications, and Rady Children's Hospital-San Diego, today announced the initiation of a study involving the use of the company's EGIR technology as a vehicle to evaluate oral and/or topical Vitamin D as a treatment for atopic dermatitis (eczema). "We are looking...